April 2, 2021
Multiple Health Conditions Lead to Compassionate Release
United States v. Maynor
2021 U.S. Dist. LEXIS 62645
Garrett R. Maynor pled guilty to one count of Manufacture of a Substance Containing Methamphetamine and was sentenced on January 10, 2011 to 168 months’ imprisonment, followed by six years of supervised release. He has been in custody since February 21, 2010 and, according to the Bureau of Prisons website, has a projected release date of February 7, 2022.
Maynor, who is 57, suffers from hypertension which has been identified by the CDC as a chronic health condition that can make him more likely to get severely ill from COVID-19. He has also experienced numerous serious infections in recent years, including MRSA and Staphylococcus that required long-term antibiotics, immunosuppressive therapy and corticosteroids. He has had three back surgeries since 2016 and required hospitalization for treatment of MRSA or staph after each one. On one occasion, he required an approximate 50-day hospitalization. Maynor now has several calcified granulomas in his lungs that are four to five centimeters in diameter that cause him shortness of breath. He also has sleep apnea. His medical records indicate that his heart rate has been in the normal to slightly elevated range and his condition is stable. Maynor made the request to the court for compassionate release or an order that he serve the remainder of his sentence in home confinement as a condition of supervised release as an alternative to a dormitory-style halfway house where there likely is a greater risk of contracting COVID-19.
The court decided that due to Maynor’s multiple underlying health conditions, and because he has served over 133 months, which is almost 80% of his 168-month sentence, he would be granted compassionate release. The conditions of his supervised release require him to spend nine months in home confinement, with the first 14 days to be spent in isolation.